Lime Chemicals Limited (507759) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Lime Chemicals Limited ₹18.84, price ₹14.30, upside +31.8%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Lime Chemicals Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range ₹11.65 – ₹40.25 · fair‑value band ₹14.38 – ₹25.32 · the ₹14.30 price screens below the ₹18.84 fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Lime Chemicals in your weekly email
Every Wednesday you see whether Lime Chemicals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Lime Chemicals Limited manufactures and sells precipitated and coated calcium carbonate primarily in India.
Show more
Lime Chemicals Limited manufactures and sells precipitated and coated calcium carbonate primarily in India. Its calcium carbonate is used as input material in various industrial sectors, such as tooth paste, pharmaceuticals, PVC products, rubber, plastic, polymer, cable, leather, papers, printing ink, food and beverages, cosmetics, animal food, dentifrices, sealants and mastics, paints, etc. Lime Chemicals Limited was founded in 1970 and is headquartered in Mumbai, India.
Stock analysis
Lime Chemicals Limited (507759) currently trades at ₹14.30, while our model-based Fair Value estimate is ₹18.84, implying the stock looks roughly 24.1% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹10.84 per share, and 0 of the 7 models we run sit above the ₹14.30 price.
Bear case: the DCF Models group reads lowest at ₹10.65, and 7 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹14.38 (bear) to ₹25.32 (bull), the price of ₹14.30 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Other sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Lime Chemicals Limited reported revenue of ₹71.2M in FY2026 versus ₹141M in FY2022, a compound −15.6%/yr. Reported net income was −₹1.7M in FY2026.
Key figures
Market cap ₹111M (≈ $1.1M) · P/E ratio 54.8 · P/S ratio 0.39 · EPS (TTM) ₹0.3000 · Net margin −2.4% · Return on equity 1,201% · Return on assets (EBIT) −3.8% · Operating margin −0.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 25% below its 52-week high and 23% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Other peers we cover trades at −10% fair-value upside, at 32%, 507759 screens cheaper than that median.
Fair Value models
Bear ₹14.38Fair Value ₹18.84Bull ₹25.32
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.1529 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.37/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−26.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−22.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−20.3%
Start year 2021 (pandemic). Over 10 years: −12.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.3%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
13.1% (2021) → −7.6% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +13.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 166 stocks
Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score40 · Bottom 25%
Fair Value upside+31.7% · Above median
Profitability
Return on assets0.0% · Above median
Net margin (TTM)−1.4% · Bottom 25%
Operating margin (TTM)−0.7% · Bottom 25%
Growth and dividend
Revenue growth−36.2% · Bottom 25%
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Other median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Lime Chemicals Limited (507759) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of ₹18.84 versus a price of ₹14.30, about +32% upside (undervalued).
What is the fair value of 507759?
Our model-based fair value for Lime Chemicals Limited is ₹18.84 (as of Oct 3, 2026), built from audited fundamentals. The current price: ₹14.30.
What is the quality score of 507759?
Lime Chemicals Limited has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lime Chemicals Limited (507759)?
Our model-based price target is the fair value of ₹18.84 (as of Oct 3, 2026) from 7 valuation models. Cautious scenario ₹14.38, optimistic scenario ₹25.32. It is a calculation from audited fundamentals, not an analyst target.
What is the Lime Chemicals Limited stock forecast for 2026?
Our models put fair value at ₹18.84, about +32% upside versus a price of ₹14.30 (undervalued). Cautious scenario ₹14.38, optimistic scenario ₹25.32. The calculation is refreshed regularly with new filings.
What growth is priced into Lime Chemicals Limited (507759)?
For today's price to be fair in a discounted-cash-flow model, Lime Chemicals Limited would have to grow free cash flow by +17.9 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -20.3 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of 507759 use?
Our models discount Lime Chemicals Limited at 10.9 %: a base by market capitalisation (nano), damped by beta 0.42, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Lime Chemicals Limited that is +17.9 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Lime Chemicals Limited (507759) delivered so far?
Over the past 5 years revenue at Lime Chemicals Limited grew -20.3 % a year. The price currently implies +17.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Lime Chemicals Limited (507759) growing?
The median revenue growth in the sector is +8.3 % a year. That is the yardstick for the growth priced into Lime Chemicals Limited (+17.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Lime Chemicals Limited (507759)?
The free-cash-flow yield on the price is 5.56 %: that much free cash flow Lime Chemicals Limited produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Lime Chemicals Limited (507759)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lime Chemicals Limited it is ₹18.84 per share (as of Oct 3, 2026), against a price of ₹14.30. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Lime Chemicals Limited stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 507759 trades below its calculated fair value: price ₹14.30, fair value ₹18.84, a gap of about +32% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 507759?
No. The price is what the market pays today (₹14.30); the fair value is what the company's own numbers justify (₹18.84). For Lime Chemicals Limited the two are ₹4.54 per share apart. That gap is exactly why we show both numbers side by side.
How much is Lime Chemicals Limited worth?
The market values Lime Chemicals Limited at about ₹111M (market capitalisation, as of Oct 3, 2026). Per share that is ₹14.30; our models calculate a fair value of ₹18.84 per share.
What do the bullish and bearish scenarios say about 507759?
Our models span a range for Lime Chemicals Limited: cautious scenario ₹14.38, base ₹18.84, optimistic ₹25.32 per share (as of Oct 3, 2026, price ₹14.30). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 507759?
Lime Chemicals Limited trades at a price-to-earnings ratio of 54.8 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹18.84 is built from several models across several years. Other multiples: P/B 0.1.
How solid is the balance sheet of Lime Chemicals Limited (507759)?
Balance-sheet figures for Lime Chemicals Limited (as of Oct 3, 2026): debt of 0.03 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is 507759 from its 52-week high?
Lime Chemicals Limited trades at ₹14.30, about 25% below its 52-week high of ₹18.99 and 23% above the low of ₹11.65 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹18.84 is for.
Which stocks are comparable to Lime Chemicals Limited?
From the same area (Other) we also value 542772, 590024, Indiabulls Real Estate Limited, KSB Pumps Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lime Chemicals Limited stock attractive at the current price?
The data as of Oct 3, 2026: price ₹14.30, calculated fair value ₹18.84 (+32%), Quality Score 40/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 507759 calculated?
We run Lime Chemicals Limited through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹18.84, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Lime Chemicals Limited currently trades 24 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lime Chemicals Limited (507759)?
The closing price on Oct 1, 2026 was ₹14.30. Our model-based fair value is ₹18.84, about +32% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lime Chemicals Limited right now?
The large discount to fair value meets weak quality (40/100). That raises the risk this is a value trap rather than a bargain. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Lime Chemicals Limited
How large is the market capitalisation of Lime Chemicals Limited (507759)?
The market capitalisation of Lime Chemicals Limited is ₹111M (≈ $1.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lime Chemicals Limited (507759)?
The price-to-sales ratio of Lime Chemicals Limited is 0.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lime Chemicals Limited (507759)?
Earnings per share at Lime Chemicals Limited are ₹0.3000 (price ÷ EPS = P/E 54.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Lime Chemicals Limited (507759)?
The net margin of Lime Chemicals Limited is −2.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lime Chemicals Limited (507759)?
The return on equity (ROE) of Lime Chemicals Limited is 1,201% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lime Chemicals Limited (507759)?
On an EBIT basis the return on assets of Lime Chemicals Limited is −3.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lime Chemicals Limited (507759)?
The operating margin of Lime Chemicals Limited is −0.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lime Chemicals Limited (507759)?
Revenue at Lime Chemicals Limited is growing −36.2% versus a year earlier (3y avg −22.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lime Chemicals Limited (507759)?
Earnings per share at Lime Chemicals Limited are growing −12.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Lime Chemicals Limited (507759) carry?
The net debt of Lime Chemicals Limited is ₹44.3M (fiscal year 2026, ≈ 8.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Lime Chemicals Limited in the live analysis
One click puts Lime Chemicals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
